Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$28.28 USD
-0.10 (-0.35%)
Updated May 17, 2024 04:00 PM ET
After-Market: $28.29 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
XRAY 28.28 -0.10(-0.35%)
Will XRAY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for XRAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XRAY
Understanding Dentsply (XRAY) Reliance on International Revenue
DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
XRAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q1 Earnings
Dentsply International (XRAY) Meets Q1 Earnings Estimates
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Other News for XRAY
Dentsply Sirona Inc. stock outperforms competitors despite losses on the day
Dentsply Sirona Inc. stock outperforms competitors on strong trading day
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Acumen Pharmaceuticals (ABOS) and DENTSPLY SIRONA (XRAY)
Dentsply Sirona Inc. stock rises Wednesday, still underperforms market
Dentsply Sirona Inc. stock underperforms Tuesday when compared to competitors